X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (28797) 28797
Publication (2619) 2619
Newsletter (1498) 1498
Newspaper Article (1299) 1299
Book Review (386) 386
Book Chapter (189) 189
Conference Proceeding (113) 113
Book / eBook (78) 78
Magazine Article (62) 62
Web Resource (40) 40
Dissertation (39) 39
Trade Publication Article (31) 31
Transcript (16) 16
Paper (9) 9
Data Set (6) 6
Report (4) 4
Government Document (3) 3
Reference (1) 1
Video Recording (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (23112) 23112
male (16223) 16223
female (16003) 16003
middle aged (12191) 12191
index medicus (12138) 12138
adult (11897) 11897
oncology (11007) 11007
aged (9519) 9519
lymphomas (9120) 9120
hematology (8302) 8302
cancer (7307) 7307
prognosis (7149) 7149
adolescent (6969) 6969
chemotherapy (5967) 5967
lymphoma (5337) 5337
child (4987) 4987
treatment outcome (4921) 4921
retrospective studies (4618) 4618
antineoplastic combined chemotherapy protocols - therapeutic use (4505) 4505
survival rate (4412) 4412
mortality (4295) 4295
risk factors (3977) 3977
research (3917) 3917
aged, 80 and over (3858) 3858
care and treatment (3759) 3759
leukemia (3720) 3720
survival analysis (3607) 3607
transplantation (3575) 3575
child, preschool (3511) 3511
non-hodgkins-lymphoma (3349) 3349
disease-free survival (3256) 3256
survival (3024) 3024
health aspects (2903) 2903
young adult (2848) 2848
lymphoma, non-hodgkin - mortality (2649) 2649
follow-up studies (2603) 2603
therapy (2518) 2518
precursor cell lymphoblastic leukemia-lymphoma - mortality (2432) 2432
neoplasm staging (2428) 2428
infant (2341) 2341
analysis (2247) 2247
immunology (2233) 2233
disease (2214) 2214
patients (2173) 2173
non-hodgkin's lymphomas (2121) 2121
combined modality therapy (2107) 2107
tumors (2067) 2067
risk (2036) 2036
stem cells (2029) 2029
animals (2025) 2025
rituximab (2020) 2020
diagnosis (1950) 1950
lymphoma - mortality (1949) 1949
recurrence (1922) 1922
remission induction (1865) 1865
children (1850) 1850
time factors (1776) 1776
lymphoma, large b-cell, diffuse - mortality (1716) 1716
cyclophosphamide - administration & dosage (1581) 1581
medical research (1581) 1581
incidence (1575) 1575
b-cell lymphoma (1573) 1573
epidemiology (1531) 1531
cancer therapies (1501) 1501
expression (1498) 1498
patient outcomes (1462) 1462
apoptosis (1458) 1458
hemic and lymphatic diseases (1455) 1455
precursor cell lymphoblastic leukemia-lymphoma - drug therapy (1442) 1442
antineoplastic agents - therapeutic use (1420) 1420
precursor cell lymphoblastic leukemia-lymphoma - therapy (1412) 1412
pediatrics (1399) 1399
studies (1399) 1399
antineoplastic combined chemotherapy protocols - adverse effects (1384) 1384
lymphoma, non-hodgkin - drug therapy (1356) 1356
vincristine - administration & dosage (1350) 1350
antineoplastic combined chemotherapy protocols - administration & dosage (1322) 1322
bone-marrow-transplantation (1315) 1315
age factors (1310) 1310
radiotherapy (1310) 1310
hematopoietic stem cell transplantation (1305) 1305
kaplan-meier estimate (1289) 1289
medical prognosis (1284) 1284
medicine (1284) 1284
lymphoma, non-hodgkin - pathology (1250) 1250
mice (1229) 1229
genetic aspects (1225) 1225
cohort studies (1221) 1221
surgery (1218) 1218
hematopoietic stem cells (1212) 1212
transplantation, homologous (1197) 1197
doxorubicin - administration & dosage (1194) 1194
lymphoma, non-hodgkin - therapy (1182) 1182
gene expression (1177) 1177
pathology (1174) 1174
proteins (1172) 1172
article (1169) 1169
bone marrow (1160) 1160
medicine, general & internal (1158) 1158
hematology, oncology and palliative medicine (1150) 1150
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (53) 53
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Media Commons - Audio Visual (1) 1
Scarborough Hospital - General (1) 1
Scarborough Hospital - Hospital Department (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
Thomas Fisher Rare Book - Rare Book (1) 1
UTL at Downsview - May be requested (1) 1
UofT Schools - Stacks (1) 1
Victoria University E.J. Pratt - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (30343) 30343
Japanese (313) 313
German (269) 269
Spanish (234) 234
French (212) 212
Chinese (173) 173
Russian (144) 144
Italian (92) 92
Polish (70) 70
Portuguese (24) 24
Norwegian (23) 23
Czech (22) 22
Hungarian (21) 21
Danish (16) 16
Dutch (13) 13
Turkish (11) 11
Croatian (9) 9
Korean (9) 9
Finnish (8) 8
Swedish (8) 8
Hebrew (7) 7
Romanian (6) 6
Serbian (6) 6
Ukrainian (5) 5
Slovak (3) 3
Bulgarian (2) 2
Persian (2) 2
Afrikaans (1) 1
Arabic (1) 1
Bosnian (1) 1
Lithuanian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 11/2010, Volume 363, Issue 22, pp. 2091 - 2101
This comparison of outcomes of allogeneic hematopoietic stem-cell transplantation in 1993–1997 and 2003–2007 shows that although patients had a somewhat poorer... 
MEDICINE, GENERAL & INTERNAL | RISK-FACTORS | URSODEOXYCHOLIC ACID | BONE-MARROW-TRANSPLANTATION | IMMUNE RECONSTITUTION | COMPLICATIONS | INVASIVE FUNGAL-INFECTIONS | RECIPIENTS | CYTOMEGALOVIRUS | VERSUS-HOST-DISEASE | CONDITIONING REGIMEN | Recurrence | Graft vs Host Disease - epidemiology | Multiple Myeloma - mortality | Humans | Middle Aged | Child, Preschool | Infant | Hematopoietic Stem Cell Transplantation - mortality | Infection - etiology | Lung Diseases - etiology | Transplantation, Homologous - mortality | Young Adult | Multiple Myeloma - therapy | Myelodysplastic Syndromes - therapy | Infection - epidemiology | Graft vs Host Disease - mortality | Bone Marrow Diseases - therapy | Kidney Diseases - epidemiology | Liver Diseases - etiology | Hematopoietic Stem Cell Transplantation - adverse effects | Adult | Child | Bone Marrow Diseases - mortality | Leukemia - therapy | Mortality - trends | Liver Diseases - epidemiology | Bilirubin - blood | Lymphoma, Non-Hodgkin - therapy | Adolescent | Creatinine - blood | Aged | Lymphoma, Non-Hodgkin - mortality | Kidney Diseases - etiology | Lung Diseases - epidemiology | Leukemia - mortality | United States | Mortality | Patient outcomes | Graft versus host reaction | Transplantation | Risk factors | Hematopoietic stem cells | Cytomegalovirus | Fungal infections | Nosocomial infections | Transplants & implants | Drug dosages | comparative outcomes research | ursodiol | liver disease | hematopoietic cell transplantation | pulmonary disease | Marrow transplantation | survival | mortality | kidney disease | graft-vs.-host disease | infectious complications
Journal Article
Journal Article
Journal Article
Gastroenterology, ISSN 0016-5085, 2015, Volume 149, Issue 6, pp. 1345 - 1360
Chronic hepatitis C virus (HCV) infection is associated with several extrahepatic manifestations. Patients with HCV may develop mixed cryoglobulinemia and its... 
Gastroenterology and Hepatology | Fatigue | Cryoglobulins | Cardiovascular Risk | Health-Related Quality of Life | Insulin Resistance | PORPHYRIA-CUTANEA-TARDA | MIXED CRYOGLOBULINEMIA VASCULITIS | PATIENT-REPORTED OUTCOMES | SUSTAINED VIROLOGICAL RESPONSE | MAGNETIC-RESONANCE-SPECTROSCOPY | POPULATION-BASED COHORT | ALPHA-2A PLUS RIBAVIRIN | QUALITY-OF-LIFE | CHRONIC HCV INFECTION | IDIOPATHIC PULMONARY-FIBROSIS | GASTROENTEROLOGY & HEPATOLOGY | Interferon-alpha - pharmacology | Vasculitis - epidemiology | Humans | Hepatitis C, Chronic - virology | Hepacivirus - pathogenicity | Vasculitis - virology | Cryoglobulinemia - virology | Hepatitis C, Chronic - mortality | Cryoglobulinemia - epidemiology | Glucose Metabolism Disorders - virology | Hepatitis C, Chronic - epidemiology | Glomerulonephritis - epidemiology | Hepacivirus - drug effects | Lymphoma - epidemiology | Antiviral Agents - pharmacology | Antiviral Agents - therapeutic use | Ribavirin - therapeutic use | Interferon-alpha - therapeutic use | Glomerulonephritis - virology | Hepatitis C, Chronic - drug therapy | Antiviral Agents - administration & dosage | Morbidity | Hepatitis C, Chronic - immunology | Glucose Metabolism Disorders - epidemiology | Ribavirin - pharmacology | Lymphoma - virology | Medical colleges | Patient outcomes | Liver | Mortality | Atherosclerosis | Insulin resistance | Lymphomas | Hepatitis C | Biological response modifiers | Hepatitis C virus
Journal Article
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 7/2009, Volume 101, Issue 14, pp. 984 - 992
Journal Article
Journal of Adolescent and Young Adult Oncology, ISSN 2156-5333, 06/2017, Volume 6, Issue 2, pp. 341 - 347
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 04/2013, Volume 72, Issue 4, pp. 517 - 524
Background As long-term treatment with antitumour necrosis factor (TNF) drugs becomes accepted practice, the risk assessment requires an understanding of... 
FACTOR-ALPHA THERAPY | TUMOR-NECROSIS-FACTOR | POSTMARKETING SURVEILLANCE | NONMELANOMA SKIN-CANCER | INCREASED RISK | FACTOR INHIBITORS | LYMPHOMA | RHEUMATOLOGY | FACTOR ANTAGONISTS |